Hubei JKT Biomedicine Co., Ltd. is committed to providing
Affordable High quality Antiviral Drugs

JKT BioPharma Co., Ltd. is a new specialty pharmaceutical enterprise jointly established by the listed company JoinTown Pharmaceutical Group Co., Ltd. (600998) and Convalife (Shanghai) Co., LTD. The company focuses itself in the development and commercialization of innovative drugs for infectious diseases, and is committed to providing affordable and high-quality new treatment solutions for patients in China and around the world.

Learn More
JKT focuses on innovative drug development
and commercialization in the field of infectious diseases
2022
JKT
It was founded in 2022
10million
JKT
Registered capital
4companies
JKT
Association of enterprises
AI Drug R&D
Dedicated to provide Chinese and global
patientsAffordable high quality Novel treatment regimen
Adopt the "3I" strategy

JKT BioPharma Co., Ltd. adopts the "3I" strategy .
By combining the strength of Wuhan Institute of Virology and Shanghai Institute.

Innovation
Innovation
JKT BioPharma Co., Ltd. adopts the "3I" strategy (Innovation, Integration and Internationalization). By combining the strength of Wuhan Institute of Virology and Shanghai Institute.
Integration
Integration
JKT BioPharma Co., Ltd. adopts the "3I" strategy (Innovation, Integration and Internationalization). By combining the strength of Wuhan Institute of Virology and Shanghai Institute.
Internationalization
Internationalization
JKT BioPharma Co., Ltd. adopts the "3I" strategy (Innovation, Integration and Internationalization). By combining the strength of Wuhan Institute of Virology and Shanghai Institute.
Strategic Cooperation

JKT BioPharma and Fukang Establishment of
new characteristic pharmaceutical

Cooperative enterprise
Cooperative enterprise
Cooperative enterprise
Cooperative enterprise
News Information
More News
JKT appeared in the 5th World Health Expo
JKT appeared in the 5th World Health Expo
From April 7 to 10, the World Health Expo 2023 opened at the Wuhan International Expo Center. Representatives of more than 1,000 enterprises, a group of academicians, experts, hospital presidents, entrepreneurs and diplomatic envoys from many countries gathered in Wuhan to showcase new products, exchange new trends and discuss the development of the big health industry based on the whole industry ecology in the big health field.
2023/05/15
Warm congratulations to Jiukangtong company landing signing, set sail!
Warm congratulations to Jiukangtong company landing signing, set sail!
On February 21, 2023, the project signing ceremony of Wuhan Airport Economic and Technological Development Zone Management Committee, Jiuzhou Tong Pharmaceutical Group Co., LTD., Hubei Jiukangtong Biological Pharmaceutical Co., Ltd. was held in Wuhan. Zhou Ming, Executive Deputy Governor of Dongxihu District, Guo Xiaoping, Deputy Governor of Dongxihu District, Leng Ying, Director of Office of Dongxihu District, Dai Lichun, Secretary of Party Group of Bureau of Commerce of Dongxihu District, Qiu Danya, Director of Bureau of Commerce of Dongxihu District, Wang Hua, Director of Food and Pharmaceutical Industry Office of Dongxihu District, Han Ying, President of Dongxihu District Investment Promotion Company, Zhang Minjie, general manager of the Company, Liu Changyun, Chairman of Jiuzhou Pharmaceutical Group, Tian Yun, executive deputy general manager, Shen Xiaokun, vice chairman of Hubei Jiukangtong Biomedicine Company, attended the signing ceremony and delivered a speech.
2023/05/15